Elisa Sala

1.4k total citations
46 papers, 842 citations indexed

About

Elisa Sala is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Elisa Sala has authored 46 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 15 papers in Molecular Biology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Elisa Sala's work include Genetic factors in colorectal cancer (8 papers), Acute Myeloid Leukemia Research (6 papers) and CAR-T cell therapy research (6 papers). Elisa Sala is often cited by papers focused on Genetic factors in colorectal cancer (8 papers), Acute Myeloid Leukemia Research (6 papers) and CAR-T cell therapy research (6 papers). Elisa Sala collaborates with scholars based in Italy, Germany and United States. Elisa Sala's co-authors include Carlo Gambacorti‐Passerini, Luca Mologni, Silvia Truffa, Carlo Gaetano, Gideon Bollag, Maurizio Ponz de Leòn, Monica Pedroni, Antonio Percesepe, Piero Benatti and Francesca Borghi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elisa Sala

43 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisa Sala Italy	17	435	373	288	134	84	46	842
Hans-Ullrich Voelker Germany	12	285 0.7×	324 0.9×	298 1.0×	376 2.8×	62 0.7×	29	997
Hendrik Nogai Germany	15	340 0.8×	404 1.1×	283 1.0×	262 2.0×	156 1.9×	35	1.0k
Anna G. Antonacopoulou Greece	21	457 1.1×	529 1.4×	73 0.3×	257 1.9×	138 1.6×	50	1.0k
Maria Lúcia Hirata Katayama Brazil	19	367 0.8×	464 1.2×	286 1.0×	279 2.1×	111 1.3×	64	1.1k
Fiona Chionh Australia	15	393 0.9×	344 0.9×	191 0.7×	142 1.1×	152 1.8×	26	839
Qunling Zhang China	15	390 0.9×	482 1.3×	164 0.6×	189 1.4×	226 2.7×	51	972
Paraskevi Alexandrou Greece	18	390 0.9×	497 1.3×	56 0.2×	280 2.1×	82 1.0×	43	922
Louise Flanagan Ireland	10	319 0.7×	282 0.8×	246 0.9×	158 1.2×	51 0.6×	13	762
Hiroki Odagiri Japan	16	393 0.9×	713 1.9×	69 0.2×	161 1.2×	152 1.8×	36	1.3k
Nam-Gyun Kim South Korea	9	157 0.4×	428 1.1×	122 0.4×	305 2.3×	151 1.8×	11	854

Countries citing papers authored by Elisa Sala

Since Specialization

Citations

This map shows the geographic impact of Elisa Sala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Sala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Sala more than expected).

Fields of papers citing papers by Elisa Sala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Sala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Sala. The network helps show where Elisa Sala may publish in the future.

Co-authorship network of co-authors of Elisa Sala

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Sala. A scholar is included among the top collaborators of Elisa Sala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Sala. Elisa Sala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koreth, John, Jeremy Pantin, Shukaib Arslan, et al.. (2025). Primary results from Equator, a Phase 3 double-blind, randomized placebo-controlled study evaluating itolizumab in combination with corticosteroids as initial treatment of acute graft-versus-host disease.. Blood. 146(Supplement 1). 274–274.

Pabst, Caroline, Michael Stadler, Johannes Schetelig, et al.. (2025). Outcome of Patients With IDH-Mutated AML Following Allogeneic Stem Cell Transplantation—A Retrospective Analysis on Behalf of the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy, DRST. Transplantation and Cellular Therapy. 31(5). 303.e1–303.e9.

Gagelmann, Nico, Matthias Stelljes, Igor Wolfgang Blau, et al.. (2024). Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantation. American Journal of Hematology. 99(8). 1540–1549. 2 indexed citations

Tresckow, Bastian von, Hans Christian Reinhardt, Christian Jehn, et al.. (2024). How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective. Frontiers in Oncology. 14. 1466803–1466803. 1 indexed citations

Sala, Elisa, Geeta G. Sharma, Maria Gemelli, et al.. (2024). New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients. npj Precision Oncology. 8(1). 29–29. 3 indexed citations

Wais, Verena, et al.. (2024). Treatment of steroid-refractory acute/chronic graft versus host disease: A single-center real-world experience of ruxolitinib in combination with extracorporeal photopheresis in a high-risk population. Leukemia Research. 147. 107611–107611. 1 indexed citations

Zambelli, Alberto, et al.. (2023). Working tables on Hormone Receptor positive (HR+), Human Epidermal growth factor Receptor 2 negative (HER2-) early stage breast cancer: Defining high risk of recurrence. Critical Reviews in Oncology/Hematology. 191. 104104–104104. 2 indexed citations

Marra, Giusy, Donatella Treppiedi, Federica Mangili, et al.. (2023). A novel filamin A-binding molecule may significantly enhance SST2 antitumoral actions in GH-secreting PitNET cells. Endocrine Abstracts. 2 indexed citations

Fürst, Daniel, I Rodé, Hubert Schrezenmeier, et al.. (2022). Monitoring the in-Vivo Expansion and Persistence of CAR-T Cells As a Tool to Help Decision Making in Patients with Aggressive B-Cell Lymphoma. Blood. 140(Supplement 1). 7527–7528. 6 indexed citations

10.

Ehninger, Gerhard, Sabrina Kraus, Elisa Sala, et al.. (2022). Phase 1 Dose Escalation Study of the Rapidly Switchable Universal CAR-T Therapy Unicar-T-CD123 in Relapsed/Refractory AML. Blood. 140(Supplement 1). 2367–2368. 27 indexed citations

11.

Cortinovis, Diego, Francesca Colonese, Luca Sala, et al.. (2022). Harnessing DLL3 inhibition: From old promises to new therapeutic horizons. Frontiers in Medicine. 9. 989405–989405. 7 indexed citations

12.

Cortinovis, Diego, Umberto Malapelle, Fabio Pagni, et al.. (2021). Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review. Translational Lung Cancer Research. 10(7). 3385–3400. 8 indexed citations

13.

Citerio, Giuseppe, Lara Prisco, Mauro Oddo, et al.. (2019). International prospective observational study on intracranial pressure in intensive care (ICU): the SYNAPSE-ICU study protocol. BMJ Open. 9(4). e026552–e026552. 7 indexed citations

14.

Cuna, Vania, Irene Capelli, Elisa Sala, et al.. (2014). Hypoacusia and Chronic Renal Dysfunction: New Etiopathogenetic Prospective. Therapeutic Apheresis and Dialysis. 19(2). 111–118. 12 indexed citations

15.

Sala, Elisa, Roberto Crocchiolo, Sara Gandolfi, et al.. (2014). Bendamustine Combined with Donor Lymphocytes Infusion in Hodgkin's Lymphoma Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(9). 1444–1447. 18 indexed citations

16.

Messina, Carlo, Anna Candoni, Matteo Giovanni Carrabba, et al.. (2014). Wilms' Tumor Gene 1 Transcript Levels in Leukapheresis of Peripheral Blood Hematopoietic Cells Predict Relapse Risk in Patients Autografted for Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 20(10). 1586–1591. 26 indexed citations

17.

Gunby, Rosalind H., Elisa Sala, Carmen Julia Tartari, et al.. (2007). Oncogenic Fusion Tyrosine Kinases as Molecular Targets for Anti-Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry. 7(6). 594–611. 26 indexed citations

18.

Sala, Elisa, Luca Mologni, Sara Cazzaniga, E. Papinutto, & Carlo Gambacorti‐Passerini. (2006). A rapid method for the purification of wild-type and V804M mutant ret catalytic domain: A tool to study thyroid cancer. International Journal of Biological Macromolecules. 39(1-3). 60–65. 3 indexed citations

19.

Tunca, Berrin, Mirco Menigatti, Piero Benatti, et al.. (2005). Investigation of APC Mutations in a Turkish Familial Adenomatous Polyposis Family by Heterodublex Analysis. Diseases of the Colon & Rectum. 48(3). 567–571. 1 indexed citations

20.

Mologni, Luca, Elisa Sala, Luca Cesaro, et al.. (2005). Expression, purification, and inhibition of human RET tyrosine kinase. Protein Expression and Purification. 41(1). 177–185. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact